Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 2
1994 4
1995 11
1996 39
1997 59
1998 89
1999 122
2000 131
2001 107
2002 45
2003 40
2004 16
2005 22
2006 12
2007 8
2008 14
2009 13
2010 12
2011 5
2012 4
2013 7
2014 8
2015 10
2016 7
2017 6
2018 7
2019 3
2020 8
2021 9
2022 5
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

806 results
Results by year
Filters applied: . Clear all
Page 1
Trovafloxacin.
[No authors listed] [No authors listed] 2021 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000189 Free Books & Documents. Review.
No information is available on the clinical use of trovafloxacin during breastfeeding; however, amounts in breastmilk appear to be low. ...However, recent studies indicate little risk.[1,2] The calcium in milk might prevent absorption of the small amounts of fluoroquinolon …
No information is available on the clinical use of trovafloxacin during breastfeeding; however, amounts in breastmilk appear to be lo …
Trovafloxacin.
Haria M, Lamb HM. Haria M, et al. Drugs. 1997 Sep;54(3):435-45; discussion 446. doi: 10.2165/00003495-199754030-00006. Drugs. 1997. PMID: 9279505 Review.
Trovafloxacin is a fluoroquinolone antibacterial agent with a broad spectrum of activity. Trovafloxacin has similar or 2-fold lower activity than ciprofloxacin against Enterobacteriaceae and Pseudomonas aeruginosa. ...
Trovafloxacin is a fluoroquinolone antibacterial agent with a broad spectrum of activity. Trovafloxacin has similar or 2-fold …
Trovafloxacin: an overview.
Garey KW, Amsden GW. Garey KW, et al. Pharmacotherapy. 1999 Jan;19(1):21-34. doi: 10.1592/phco.19.1.21.30507. Pharmacotherapy. 1999. PMID: 9917076 Review.
Trovafloxacin, a new synthetic naphthyridine fluoroquinolone antibiotic, is a broad-spectrum agent available orally and intravenously. ...Trovafloxacin may prove beneficial as it allows for oral or intravenous monotherapy against indicated infections that normally r …
Trovafloxacin, a new synthetic naphthyridine fluoroquinolone antibiotic, is a broad-spectrum agent available orally and intravenously …
Trovafloxacin: a new fluoroquinolone.
Alghasham AA, Nahata MC. Alghasham AA, et al. Ann Pharmacother. 1999 Jan;33(1):48-60. doi: 10.1345/aph.17460. Ann Pharmacother. 1999. PMID: 9972385 Review.
The oral bioavailability under fasting conditions is approximately 88%. The elimination half-life of trovafloxacin is approximately 10 hours. Less than 10% of trovafloxacin is eliminated unchanged in the urine. ...The common adverse effects of trovafloxacin i …
The oral bioavailability under fasting conditions is approximately 88%. The elimination half-life of trovafloxacin is approximately 1 …
[Trovafloxacin].
Azanza JR, Ollero D, Sádaba B, García Quetglas E. Azanza JR, et al. Rev Med Univ Navarra. 1999 Jan-Mar;43(1):45-57. Rev Med Univ Navarra. 1999. PMID: 10386346 Review. Spanish. No abstract available.
Levofloxacin and trovafloxacin: the next generation of fluoroquinolones?
Ernst ME, Ernst EJ, Klepser ME. Ernst ME, et al. Am J Health Syst Pharm. 1997 Nov 15;54(22):2569-84. doi: 10.1093/ajhp/54.22.2569. Am J Health Syst Pharm. 1997. PMID: 9397218 Review.
Trovafloxacin is more potent than existing quinolones against gram-positive bacteria. ...Levofloxacin can therefore be administered once daily for mild to moderate infections and twice daily for more serious infections. The recommended daily dose is 500 mg. Trovafloxaci …
Trovafloxacin is more potent than existing quinolones against gram-positive bacteria. ...Levofloxacin can therefore be administered o …
Trovafloxacin drives inflammation-associated drug-induced adverse hepatic reaction by changing macrophage polarization.
Yang H, Park T, Park D, Kang MG. Yang H, et al. Toxicol In Vitro. 2022 Aug;82:105374. doi: 10.1016/j.tiv.2022.105374. Epub 2022 May 9. Toxicol In Vitro. 2022. PMID: 35537566 Free article.
However, little is known about the mechanism by which drugs facilitate the activation of the innate immune system. Here, we aimed to decipher the inflammatory events in trovafloxacin (TVX)-induced reactions using liver macrophages. We showed that proinflammatory M1-like ma …
However, little is known about the mechanism by which drugs facilitate the activation of the innate immune system. Here, we aimed to deciphe …
Trovafloxacin-associated leukopenia.
Mitropoulos FA, Angood PB, Rabinovici R. Mitropoulos FA, et al. Ann Pharmacother. 2001 Jan;35(1):41-4. doi: 10.1345/aph.10066. Ann Pharmacother. 2001. PMID: 11197584
OBJECTIVE: To report a case of trovafloxacin-associated leukopenia, which occurred in a trauma patient shortly after administration and resolved following discontinuation of the drug. ...Healthcare personnel should be aware of this possible adverse reaction in patients tre …
OBJECTIVE: To report a case of trovafloxacin-associated leukopenia, which occurred in a trauma patient shortly after administration a …
Trovafloxacin neurotoxicity.
Menzies D, Klein NC, Cunha BA. Menzies D, et al. Am J Med. 1999 Sep;107(3):298-9. doi: 10.1016/s0002-9343(99)00186-2. Am J Med. 1999. PMID: 10492332 Free article. No abstract available.
Trovafloxacin hepatotoxicity.
Lazarczyk DA, Goldstein NS, Gordon SC. Lazarczyk DA, et al. Dig Dis Sci. 2001 Apr;46(4):925-6. doi: 10.1023/a:1010741510046. Dig Dis Sci. 2001. PMID: 11330435
A 19-year-old woman was treated for recurrent sinusitis with oral trovafloxacin and developed acute hepatitis and peripheral eosinophilia, with hepatosplenomegaly and ascites. ...Clinical and laboratory abnormalities resolved completely after prolonged treatment with stero …
A 19-year-old woman was treated for recurrent sinusitis with oral trovafloxacin and developed acute hepatitis and peripheral eosinoph …
806 results